Company Filing History:
Years Active: 2025
Title: Maoxue Tang: Innovator in Biologic Treatments
Introduction
Maoxue Tang is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of biologic treatments, particularly in relation to the SLC2A1 gene. His innovative work focuses on addressing critical health conditions through advanced therapeutic methods.
Latest Patents
Maoxue Tang holds a patent for "SLC2A1 lncRNA as a biologic and related treatments." This invention pertains to a novel antisense transcript to the human SLC2A1 (Glut1) gene, including its variants and fragments. The antisense transcript can be utilized to modulate Glut1 expression, serving to restore Glut1 levels. This therapeutic approach aims to treat or prevent Glut1 deficiency syndrome and other related conditions, such as certain cancers, diabetes, Alzheimer's disease, and retinitis pigmentosa. He has 1 patent to his name.
Career Highlights
Maoxue Tang is affiliated with Columbia University, where he conducts research and develops innovative solutions in the field of genetics and therapeutics. His work has garnered attention for its potential impact on various health issues.
Collaborations
He collaborates with Umrao Monani, contributing to advancements in their shared field of research.
Conclusion
Maoxue Tang's contributions to biologic treatments highlight the importance of innovation in addressing complex health challenges. His work continues to pave the way for new therapeutic options that can significantly improve patient outcomes.